408 related articles for article (PubMed ID: 19105621)
1. Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial.
Yeo C; Mathur A
Regen Med; 2009 Jan; 4(1):119-27. PubMed ID: 19105621
[TBL] [Abstract][Full Text] [Related]
2. Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study.
Mozid A; Yeo C; Arnous S; Ako E; Saunders N; Locca D; Brookman P; Archbold RA; Rothman M; Mills P; Agrawal S; Martin J; Mathur A
Regen Med; 2014 May; 9(3):269-78. PubMed ID: 24935040
[TBL] [Abstract][Full Text] [Related]
3. The Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGENERATE-DCM) trial: study design.
Arnous S; Mozid A; Mathur A
Regen Med; 2011 Jul; 6(4):525-33. PubMed ID: 21749209
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
Ripa RS
Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.
Perin EC; Silva GV; Zheng Y; Gahremanpour A; Canales J; Patel D; Fernandes MR; Keller LH; Quan X; Coulter SA; Moore WH; Herlihy JP; Willerson JT
Am Heart J; 2012 Mar; 163(3):415-21, 421.e1. PubMed ID: 22424012
[TBL] [Abstract][Full Text] [Related]
6. An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial.
Choudhury T; Mozid A; Hamshere S; Yeo C; Pellaton C; Arnous S; Saunders N; Brookman P; Jain A; Locca D; Archbold A; Knight C; Wragg A; Davies C; Mills P; Parmar M; Rothman M; Choudry F; Jones DA; Agrawal S; Martin J; Mathur A
Eur J Heart Fail; 2017 Jan; 19(1):138-147. PubMed ID: 27790824
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of progenitor cells in ischemic heart disease--Past, present and future.
Hristov M; Weber C
Basic Res Cardiol; 2006 Jan; 101(1):1-7. PubMed ID: 16382288
[TBL] [Abstract][Full Text] [Related]
9. [Stem cells after myocardial infarction].
Schächinger V; Dimmeler S; Zeiher AM
Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived stem cell therapy in ischemic heart disease.
Cho HJ; Lee J; Wecker A; Yoon YS
Regen Med; 2006 May; 1(3):337-45. PubMed ID: 17465787
[TBL] [Abstract][Full Text] [Related]
11. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.
Kaushal S; Jacobs JP; Gossett JG; Steele A; Steele P; Davis CR; Pahl E; Vijayan K; Asante-Korang A; Boucek RJ; Backer CL; Wold LE
Cardiol Young; 2009 Nov; 19 Suppl 2():74-84. PubMed ID: 19857353
[TBL] [Abstract][Full Text] [Related]
12. Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis.
Wen Y; Meng L; Xie J; Ouyang J
Expert Opin Biol Ther; 2011 May; 11(5):559-67. PubMed ID: 21388335
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
14. Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease.
Donndorf P; Strauer BE; Haverich A; Steinhoff G
Curr Pharm Biotechnol; 2013; 14(1):12-9. PubMed ID: 23092255
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study--congestive heart failure trial (DanCell-CHF).
Diederichsen AC; Møller JE; Thayssen P; Junker AB; Videbaek L; Saekmose SG; Barington T; Kristiansen M; Kassem M
Eur J Heart Fail; 2008 Jul; 10(7):661-7. PubMed ID: 18555742
[TBL] [Abstract][Full Text] [Related]
16. [Stem cell therapy in ischemic heart disease].
Diederichsen AC; Møller JE; Kristiansen MA; Saekmose SG; Barington T; Videbaek LM; Kassem MS; Thayssen P
Ugeskr Laeger; 2006 Mar; 168(11):1111-4. PubMed ID: 16545213
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic effect of autologous bone marrow cells in ischemic heart disease].
Hristov M; Keymel S; Weber C
Med Klin (Munich); 2006 Mar; 101 Suppl 1():186-9. PubMed ID: 16802551
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).
Perin EC; Silva GV; Henry TD; Cabreira-Hansen MG; Moore WH; Coulter SA; Herlihy JP; Fernandes MR; Cheong BY; Flamm SD; Traverse JH; Zheng Y; Smith D; Shaw S; Westbrook L; Olson R; Patel D; Gahremanpour A; Canales J; Vaughn WK; Willerson JT
Am Heart J; 2011 Jun; 161(6):1078-87.e3. PubMed ID: 21641354
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of stem cells in cardiac diseases.
Strauer BE; Schannwell CM; Brehm M
Minerva Cardioangiol; 2009 Apr; 57(2):249-67. PubMed ID: 19274033
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of using autologous mono-nuclears of the bone marrow in treatment of patients with ischemic heart disease].
Sedov VM; Nemkov AS; Afanas'ev BV; Zverev OG; Nesterko AO; Fregatova LM; Belyĭ SA; Shloĭdo EA; Iudina OV; Ryzhkova DV; Zueva EE; Petrov NV; Stovpiuk OF; Tsurupa SP
Vestn Khir Im I I Grek; 2006; 165(4):11-4. PubMed ID: 17120413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
